ArticleApoptosis : an international journal on programmed cell death2020

Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination.

Maria Cosenza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.